News

Sandoz generic injectable acetaminophen, developed by Milla Pharmaceuticals, immediately available to US patients upon launch On 8 December 2020, Sandoz announced the US launch of its generic injectable acetaminophen (paracetamol IV), available as 100 mL glass vial containing 1,000 mg acetaminophen (10 mg/mL). The generic drug is used in adult and pediatric patients of two years and older to relieve mild to moderate pain and to treat moderate to severe pain in conjunction with opioid analgesics. It can also be used to reduce fever. “At Sandoz, we are continuously growing our injectable medicines portfolio to ensure patients across the US...